ST JOHN'S WORT

Drug action

Interactions

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefits/risk balance of the medicinal product. In the UK, healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme

This item requires a subscription.For full access to this content, log in to an existing user account or purchase an individual subscription.